United States · FDA National Drug Code directory

Ipratropium Bromide Inhalation

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 17270-0401_be83ceac-679d-42c3-960d-536709b5df99
Product NDC: 17270-0401
Form: AEROSOL
Composition / generic term: Ipratropium Bromide Inhalation
Labeler: Armstrong Pharmaceuticals, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20260416
Source listing expiry: 20271231

Source-listed ingredients

IPRATROPIUM BROMIDE — 17 ug/1

These values do not establish equivalence or a dose recommendation.

Packages

1 CANISTER in 1 CARTON (17270-0401-0) / 200 AEROSOL in 1 CANISTER · 17270-0401-0

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →